retatrutide benefits clinical trial retatrutide Today, we shared new data from two Phase 3 trials of retatrutide, our investigational triple agonist. Learn more: https://go.lilly.com/msrz1v Retatrutide Side Effects Guide: 21

Both peptides belong to the incretin family, but they target different combinations of hormone receptors

They can't compete with prescription treatments

Finally, a rare but serious side effect of GLP-1 receptor agonists is a potential risk for thyroid cancer

They are often injectable medications that are combined with other treatmentssuch as diet, exercise, medication, or bariatric surgeryto promote weight loss and manage blood sugar levels

Compounded semaglutide is not FDA-approved, is not the same as these brand-name products, and has not been reviewed by the FDA for safety or effectiveness

Usually Botox is done every 3 -4 months